Cost‐effectiveness of first‐line immunotherapies for advanced non‐small cell lung cancer

por Yang, Szu‐Chun, Ou, Huang‐Tz, Su, Wu‐Chou, Wang, Shi‐Yi
Publicado 2023

Overcoming Radiation Resistance by Iron-Platinum Metal Alloy Nanoparticles in Human Copper Transport 1-Overexpressing Cancer Cells via Mitochondrial Disturbance

por Tsai, Tsung-Lin, Lai, Yu-Hsuan, HW Chen, Helen, Su, Wu-Chou
Publicado 2021

CD40 Pathway and IL-2 Expression Mediate the Differential Outcome of Colorectal Cancer Patients with Different CSF1R c.1085 Genotypes

por Yeh, Yu-Min, Lin, Peng-Chan, Su, Wu-Chou, Shen, Meng-Ru
Publicado 2021

Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naïve Metastatic Lung Adenocarcinoma

por Yang, Szu-Chun, Lin, Chien-Chung, Chen, Yi-Lin, Su, Wu-Chou
Publicado 2022

The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer

por Huang, Wei-Lun, Wei, Fang, Wong, David T., Lin, Chien-Chung, Su, Wu-Chou
Publicado 2015

A Liposomal Formulation Able to Incorporate a High Content of Paclitaxel and Exert Promising Anticancer Effect

por Kan, Pei, Tsao, Chih-Wan, Wang, Ae-June, Su, Wu-Chou, Liang, Hsiang-Fa
Publicado 2011

Nanomedicine-Based Strategies Assisting Photodynamic Therapy for Hypoxic Tumors: State-of-the-Art Approaches and Emerging Trends

por Shih, Chun-Yan, Wang, Pei-Ting, Su, Wu-Chou, Teng, Hsisheng, Huang, Wei-Lun
Publicado 2021

PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells

por Su, Wen-Pin, Cheng, Fong-Yu, Shieh, Dar-Bin, Yeh, Chen-Sheng, Su, Wu-Chou
Publicado 2012

An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells

por Chiu, Wei-Hsin, Su, Wu-Chou, Li, Chia-Ling, Chen, Chia-Ling, Lin, Chiou-Feng
Publicado 2015

Autophagy regulates vinorelbine sensitivity due to continued Keap1-mediated ROS generation in lung adenocarcinoma cells

por Wu, Yan-Wei, Lin, Chiou-Feng, Lin, Yee-Shin, Su, Wu-Chou, Chiu, Wei-Hsin
Publicado 2018

Iron Release Profile of Silica-Modified Zero-Valent Iron NPs and Their Implication in Cancer Therapy

por Yang, Li-Xing, Wu, Ya-Na, Wang, Pei-Wen, Su, Wu-Chou, Shieh, Dar-Bin
Publicado 2019

Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan

por Yang, Szu-Chun, Lai, Wu-Wei, Hsu, Jason C., Su, Wu-Chou, Wang, Jung-Der
Publicado 2020

Immune Checkpoint Inhibitor-Induced Myasthenia Gravis

por Huang, Yi-Te, Chen, Ya-Ping, Lin, Wen-Chih, Su, Wu-Chou, Sun, Yuan-Ting
Publicado 2020

First‐line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation‐positive non‐small cell lung cancer

por Su, Po‐Lan, Chen, Chian‐Wei, Wu, Yi‐Lin, Lin, Chien‐Chung, Su, Wu‐Chou
Publicado 2020

Development of the CK‐MB‐1 trastuzumab‐resistant HER2‐positive breast cancer cell line and xenograft animal models

por Chung, Wei‐Pang, Huang, Wei‐Lun, Liao, Wei‐An, Huang, Wan‐Ling, Liu, You‐Yu, Su, Wu‐Chou
Publicado 2021

Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung Cancer

por Yang, Szu-Chun, Kunst, Natalia, Gross, Cary P., Wang, Jung-Der, Su, Wu-Chou, Wang, Shi-Yi
Publicado 2021

Upregulation of Tissue Factor by Activated Stat3 Contributes to Malignant Pleural Effusion Generation via Enhancing Tumor Metastasis and Vascular Permeability in Lung Adenocarcinom...

por Yeh, Hsuan-Heng, Chang, Wen-Tsan, Lu, Kuang-Chu, Lai, Wu-Wei, Liu, Hsiao-Sheng, Su, Wu-Chou
Publicado 2013

The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis

por Chang, Wei-Yuan, Wu, Yi-Lin, Su, Po-Lan, Yang, Szu-Chun, Lin, Chien-Chung, Su, Wu-Chou
Publicado 2018

Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors

por Tsai, Hui-Jen, Shiah, Her-Shyong, Chang, Jang-Yang, Su, Wu-Chou, Chiang, Nai-Jung, Chen, Li-Tzong
Publicado 2021

Durable Response to Combined Dabrafenib and Trametinib in a Patient With BRAF K601E Mutation-Positive Lung Adenocarcinoma: A Case Report

por Su, Po-Lan, Lin, Chien-Yu, Chen, Yi-Lin, Chen, Wan-Li, Lin, Chien-Chung, Su, Wu-Chou
Publicado 2021